ROSEWELL Trademark

Trademark Overview


On Wednesday, July 17, 2024, a trademark application was filed for ROSEWELL with the United States Patent and Trademark Office. The USPTO has given the ROSEWELL trademark a serial number of 98654038. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 29, 2025. This trademark is owned by RoseWell Pharmaceuticals LLC. The ROSEWELL trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics; Antihistamines; Aspirin; Decongestants; Expectorants; Allergy medications; Allergy relief medication; Analgesic preparations; Analgesic and anti-inflammatory preparations; Anti-tussive expectorants; Antiallergic medicines; Cough drops; Cough expectorants; Cough lozenges; Cough pastilles for medical use; Cough syrups; Cough syrups for medical use; Cough treatment preparations; Decongestant capsules; Decongestant nasal sprays; Ibuprofen for use as an oral analgesic; Medicated lozenges; Non-medicated topical gel for the prevention and treatment of cold and flu; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for the treatment and prevention of acne and pimples; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Preparations for treating co...
rosewell

General Information


Serial Number98654038
Word MarkROSEWELL
Filing DateWednesday, July 17, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements


Goods and ServicesAnalgesics; Antihistamines; Aspirin; Decongestants; Expectorants; Allergy medications; Allergy relief medication; Analgesic preparations; Analgesic and anti-inflammatory preparations; Anti-tussive expectorants; Antiallergic medicines; Cough drops; Cough expectorants; Cough lozenges; Cough pastilles for medical use; Cough syrups; Cough syrups for medical use; Cough treatment preparations; Decongestant capsules; Decongestant nasal sprays; Ibuprofen for use as an oral analgesic; Medicated lozenges; Non-medicated topical gel for the prevention and treatment of cold and flu; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for the treatment and prevention of acne and pimples; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Preparations for treating colds; Anti-cough drops; Oral analgesics; Topical analgesics
Pseudo MarkROSE WELL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoseWell Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92128-2538

Party NameRoseWell Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92128-2538

Trademark Events


Event DateEvent Description
Thursday, July 18, 2024NEW APPLICATION ENTERED
Thursday, February 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 7, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 7, 2025ASSIGNED TO EXAMINER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 29, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT